This brand name is authorized in Spain
The drug FOLIFERRON contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Folic acid
UNII 935E97BOY8 - FOLIC ACID
|
|
Folic acid is a member of the vitamin B group which is reduced in the body to tetrahydrofolate, a co-enzyme active in several metabolic processes and produces a haemopoietic response in nutritional megaloblastic anaemias. Folic acid is rapidly absorbed and widely distributed in body tissues. |
|
2
Ferrous fumarate
UNII R5L488RY0Q - FERROUS FUMARATE
|
|
Ferrous fumarate is an easily absorbed source of iron for replacement therapy. It is a salt of ferrous iron with an organic acid and is less irritant to the gastro-intestinal tract than salts with inorganic acids. Iron and iron salts should be given for the treatment or prophylaxis of iron deficiency anaemias. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| B03AD02 | Ferrous fumarate and folic acid | B Blood and blood forming organs → B03 Antianemic preparations → B03A Iron preparations → B03AD Iron in combination with folic acid |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 40613 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
